Dostinex (cabergoline) tablets label

First Page		Document Content
Date: 2011-07-19 14:29:18 Lysergamides Cabergoline Prolactinoma Chemistry Dopamine agonists Organic chemistry		Dostinex (cabergoline) tablets label Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 187,77 KB Share Document on Facebook

	DOC Document DocID: TJ5M - View Document
	Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study Adrian F. Daly, Maria A. Tichomirowa, Patrick Petrossians, Elina He DocID: REgO - View Document
	0021-972X/98/$[removed]Journal of Clinical Endocrinology and Metabolism Copyright © 1998 by The Endocrine Society Vol. 83, No. 2 Printed in U.S.A. DocID: Rkgw - View Document
	WPA EDUCATIONAL MODULE Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level MARC DE HERT1, DAN COH DocID: NNQ7 - View Document
	Page 1 of 7 SAMPLE INFORMED CONSENT # 5 Client Information for Informed Consent FEMINIZING MEDICATIONS FOR TRANSGENDER CLIENTS/Minors and DocID: NzYF - View Document